Skip to main content
. 2017 May 27;143(10):1947–1957. doi: 10.1007/s00432-017-2408-4

Table 2.

Two-year overall survival (OS) rates of AXLLow and AXLHigh tumors in NSCLC metastasis and NSCLC BM groups

NSCLC metastases NSCLC brain metastases
Median OS (months)
 Low AXL (mo) 35 48
 High AXL (mo) 24 21
2-year survival rates
 Low AXL (%) 65.1 68.8
 High AXL (%) 48.3 44.8